[HTML][HTML] Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment
BA Siddiqui, M Zhang, LL Pisters… - … andrology and urology, 2020 - ncbi.nlm.nih.gov
Testicular germ cell tumors are the most common solid tumors in young men. These cancers
represent a success story of modern medicine in our ability to cure young patients and offer …
represent a success story of modern medicine in our ability to cure young patients and offer …
[HTML][HTML] Testicular seminoma clinical stage 1: treatment outcome on a routine care level
KP Dieckmann, I Dralle-Filiz, C Matthies… - Journal of cancer …, 2016 - Springer
Abstract Purpose Clinical stage 1 (CS1) testicular seminoma involves an almost 100%
disease-specific survival in controlled clinical trials. We aimed to find out whether these …
disease-specific survival in controlled clinical trials. We aimed to find out whether these …
[HTML][HTML] A Systematic Review Investigating the Difference between 1 Cycle versus 2 Cycles of Adjuvant Chemotherapy in Stage I Testicular Germ Cell Cancers
EF Rohozneanu, C Deac, CI Căinap - Medicina, 2023 - mdpi.com
Standard care for stage I testicular germ cell cancers (seminomatous—STC or non-
seminomatous—NSTC) is orchiectomy followed by active surveillance, 1 or 2 cycles of …
seminomatous—NSTC) is orchiectomy followed by active surveillance, 1 or 2 cycles of …
Update on the Management of Low-stage Seminoma
L Xia, S Daneshmand - Urologic Clinics, 2024 - urologic.theclinics.com
Testicular cancer, although relatively rare, represents the most common solid malignancy
among men aged between 20 and 34 years. 1–3 The incidence rates of testicular cancer …
among men aged between 20 and 34 years. 1–3 The incidence rates of testicular cancer …
Testicular Cancer Radiotherapy
AR Mahal, JB Yu - Radiation Therapy for Genitourinary Malignancies: A …, 2021 - Springer
Testicular cancer is a common genitourinary malignancy among men which can be treated
successfully with excellent survival outcomes. Reviewing new studies and national …
successfully with excellent survival outcomes. Reviewing new studies and national …
Reply to 'The challenge to one course carboplatin in seminoma clinical stage 1'by Dieckmann and Anheuser
T Tandstad, G Cohn-Cedermark - Annals of Oncology, 2016 - annalsofoncology.org
We appreciate the comments by Dieckmann and Anheuser [1] regarding our treatment
results in clinical stage I seminoma from the SWENOTECA group [2]. We do agree to the …
results in clinical stage I seminoma from the SWENOTECA group [2]. We do agree to the …